Funder Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Department of Defense  

$7,082,059.00
Fiscal Year: 2010

Download 2010 Department of Defense projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Strategic Plan Objective Institution
Characterization of the pathological and biochemical markers that correlate to the clinical features of autism Wegiel, Jerzy Q2.Other Research Foundation for Mental Hygiene, Inc.
Role of autism-susceptibility gene, CNTNAP2, in neural circuitry for vocal communication White, Stephanie Q2.Other University of California, Los Angeles
Characterization of the pathological and biochemical markers that correlate to the clinical features of autism Wisniewski, Thomas Q2.Other Research Foundation for Mental Hygiene, Inc.
Excessive cap-dependent translation as a molecular mechanism underlying ASD Klann, Eric Q2.Other New York University
Neural basis of empathy and its dysfunction in autism spectrum disorders (ASD) Platt, Michael Q2.Other Duke University
MeHG stimulates antiapoptotic signaling in stem cells Bressler, Joseph Q3.S.F Kennedy Krieger Institute
Immunopathogenesis in autism: Regulatory T cells and autoimmunity in neurodevelopment DeWitt, Jamie Q3.S.F East Carolina University
Analysis of the small intestinal microbiome of children with autism Kushak, Rafail Q3.S.I Massachusetts General Hospital
Toxicant-induced autism and mitochondrial modulation of nuclear gene expression Wlodarczyk, Bogdan Q3.S.J Texas A&M University
Discordant monozygotic twins as a model for genetic-environmental interaction in autism Feinberg, Andrew Q3.S.J Johns Hopkins University
Discordant monozygotic twins as a model for genetic-environmental interaction in autism Kaufmann, Walter Q3.S.J Kennedy Krieger Institute
Epigenetic regulation of the autism susceptibility gene, ENGRAILED 2 (EN2) Millonig, James Q3.S.J University of Medicine & Dentistry of New Jersey - Robert Wood Johnson Medical School
The transcription factor PLZF: A possible genetic link between immune dysfunction and autism Sant'Angelo, Derek Q3.L.B Memorial Sloan-Kettering Cancer Center
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Ascherio, Alberto Q3.L.C Harvard University
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Santangelo, Susan Q3.L.C Massachusetts General Hospital
Maternal risk factors for autism spectrum disorders in children of the Nurses' Health Study II Weisskopf, Marc Q3.L.C Harvard University
Development of a high-content neuronal assay to screen therapeutics for the treatment of cognitive dysfunction in autism spectrum disorders Bear, Mark Q4.S.B Massachusetts Institute of Technology
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Pedersen, Cort Q4.S.B University of North Carolina at Chapel Hill
Novel strategies to manipulate Ube3a expression for the treatment of autism and Angelman syndrome Roth, Bryan Q4.S.B University of North Carolina at Chapel Hill
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Jarstfer, Michael Q4.S.B University of North Carolina at Chapel Hill
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders - 1 Lipton, Stuart Q4.S.B Burnham Institute
Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes Moy, Sheryl Q4.S.B University of North Carolina at Chapel Hill
Interaction between MEF2 and MECP2 in the pathogenesis of autism spectrum disorders -2 Nakanishi, Nobuki Q4.S.B Burnham Institute
Novel probiotic therapies for autism Patterson, Paul Q4.S.B California Institute of Technology
Intranasal oxytocin for the treatment of children and adolescents with autism spectrum disorders (ASD) Anagnostou, Evdokia Q4.S.C Holland Bloorview Kids Rehabilitation Hospital